The level of NPY receptor mRNA expression in diet-induced obese and resistant mice.
Some mice become obese whereas others remain lean when raised on a high-energy diet. This study examined the levels of neuropeptide Y (NPY), and of Y1, Y2, Y5 and leptin receptor mRNA expression in the hypothalamic arcuate nucleus (Arc) of chronic high-energy diet-induced obese (DIO) and resistant (DR) mice. Forty mice were divided into two groups and fed either a high-fat (HF: 40% of calories from fat, 20% of calories from saturated fat; n=34) or low-fat (LF: 10% of calories from fat, 1% from saturated fat; n=6) diet. After 22 weeks of feeding, visceral fat accumulation was 69% higher in DIO mice compared with DR mice, and the former showed a moderate level of glucose intolerance. In DIO mice, the levels of NPY and leptin receptor mRNA expressions were significantly higher than in LF mice (+32 and +14%, P<0.001 and 0.05 respectively), indicating central leptin resistance, whereas the DR and LF groups did not differ. The level of Y2 receptor mRNA expression was similar between the DIO and LF groups but, importantly, was reduced approximately 20% in DR mice (P<0.005). The level of Y5 receptor mRNA was 36% lower in DR mice than DIO mice (P<0.05). The differences between DIO and DR mice identified by this study may assist in a better understanding of genetic predisposition to an increased fat deposition induced by a chronic high-fat diet. A low level of Y2 and Y5 receptor mRNA expression may contribute to the prevention of chronic high-energy diet-induced obesity in DR mice.
Huang
Xu-Feng
XF
Molecular Neurobiology Laboratory, Department of Biomedical Science, University of Wollongong, Northfield Avenue, Wollongong NSW2522, Australia. xu_feng_huang@uow.edu.au
Han
Mei
M
Storlien
Len H
LH
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000166:cytology / Q000378:metabolism; D001786:Blood Glucose / Q000235:genetics; D001824:Body Constitution / Q000235:genetics; D001835:Body Weight / Q000235:genetics; D015536:Down-Regulation / Q000235:genetics; D002149:Energy Intake / Q000502:physiology; D005526:Food, Formulated; D005786:Gene Expression Regulation / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D007031:Hypothalamus / Q000166:cytology / Q000378:metabolism*; D007113:Immunity, Innate / Q000235:genetics*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009478:Neuropeptide Y / Q000378:metabolism*; D009765:Obesity / Q000235:genetics* / Q000378:metabolism* / Q000503:physiopathology; D009929:Organ Size / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000235:genetics; D054411:Receptors, Leptin; D017476:Receptors, Neuropeptide Y / Q000235:genetics*
D001786:Blood Glucose; D009478:Neuropeptide Y; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D017476:Receptors, Neuropeptide Y